<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        129-9-16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VOLTAREN 75 MG AMP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Parenteral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection/infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        30.70
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LEK PHARMACEUTICAL D.D" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LEK PHARMACEUTICAL D.D
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac sodium, the active ingredient in Voltaren Ampoules, is one of a group of medicines</p><p>called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and</p><p>inflammation.</p><p>The intramuscular injection is used to treat a number of painful conditions including:</p><p>&bull; &#39;Flare-ups&#39; of joint or back pain</p><p>&bull; Attacks of gout</p><p>&bull; Pain caused by kidney stones</p><p>&bull; Pain caused by injuries.</p><p>&nbsp;</p><p>Voltaren Ampoules can either be given as an injection into the muscle, or as a slow infusion</p><p>into a vein. The intravenous infusion is used in hospitals to prevent or treat pain following an</p><p>operation.</p><p>&nbsp;</p><p>Voltaren Ampoules are not suitable for children.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. </strong><strong>Do not use Voltaren Ampules</strong></p><p><strong>Talk to your doctor if:</strong></p><p>&bull; you think you may be allergic to diclofenac sodium, sodium metabisulphite, aspirin,</p><p>ibuprofen or any other NSAID, or to any of the other ingredients of Voltaren Ampoules.</p><p>(These are listed at the end of the leaflet.) Signs of a hypersensitivity reaction include</p><p>swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash</p><p>or any other allergic type reaction</p><p>&bull; you have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or</p><p>bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying</p><p>bowels, fresh blood in faeces or black, tarry faeces)</p><p>&bull; you have had stomach or bowel problems after you have taken other NSAIDs</p><p>&bull; you have heart, kidney or liver failure</p><p>&bull; if you have established heart disease and/or cerebrovascular disease e.g. if you have had</p><p>a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or</p><p>brain or an operation to clear bypass blockages</p><p>&bull; if you have or have had problems with your blood circulation (peripheral arterial</p><p>disease)</p><p>&bull; you are more than six months pregnant</p><p><strong>&nbsp;</strong></p><p><strong>b. </strong><strong>Take special care with Voltaren Ampules</strong></p><p><strong>You should also ask yourself these questions before having a </strong><strong>Voltaren Ampules:</strong></p><p>&bull; Do you suffer from any bowel disorders including ulcerative colitis or Crohn&#39;s disease?</p><p>&bull; Do you have kidney or liver problems, or are you elderly?</p><p>&bull; Do you suffer from any blood or bleeding disorder?</p><p>&bull; Do you have a condition called porphyria?</p><p>&bull; Have you ever had asthma?</p><p>&bull; Are you breastfeeding?</p><p>&bull; Do you have angina, blood clots, high blood pressure, abnormally high levels of fat in</p><p>your blood (raised cholesterol or raised triglycerides)</p><p>&bull; Do you have heart problems, or have you had a stroke, or do you think you might be</p><p>at risk of these conditions (for example, if you have high blood pressure, diabetes or</p><p>high cholesterol or are a smoker)?</p><p>&bull; Do you have diabetes?</p><p>&bull; Do you smoke?</p><p>&bull; Do you have Lupus (SLE) or any similar condition?</p><p>&bull; Could you be suffering from dehydration?</p><p>&bull; Have you suffered any heavy loss of blood recently?</p><p><strong>&nbsp;</strong></p><p><strong>If the answer to any of these questions is YES, discuss your treatment with your doctor or</strong></p><p><strong>pharmacist because </strong><strong>Voltaren </strong><strong>Ampoules might not be the right medicine for you.</strong></p><p><strong>&nbsp;</strong></p><p><strong>c. Taking other medicines, herbal or dietary supplements</strong></p><p>Some medicines can interfere with your treatment. Tell your doctor or pharmacist if you are</p><p>taking any of the following:</p><p>&bull; Medicines to treat diabetes</p><p>&bull; Anticoagulants (blood thinning tablets like warfarin)</p><p>&bull; Diuretics (water tablets)</p><p>&bull; Lithium (used to treat some mental problems)</p><p>&bull; Methotrexate (for some inflammatory diseases and some cancers)</p><p>&bull; Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after</p><p>transplants)</p><p>&bull; Trimethoprim (a medicine used to prevent or treat urinary tract infections)</p><p>&bull; Quinolone antibiotics (for infections)</p><p>&bull; Any other NSAID or COX-2 (cyclo-oxgenase-2) inhibitor, for example aspirin or</p><p>ibuprofen</p><p>&bull; Mifepristone (a medicine used to terminate pregnancy)</p><p>&bull; Cardiac glycosides (for example digoxin), used to treat heart problems</p><p>&bull; Medicines known as SSRIs used to treat depression</p><p>&bull; Oral steroids (an anti-inflammatory drug)</p><p>&bull; Medicines used to treat heart conditions or high blood pressure, for example betablockers</p><p>or ACE inhibitors.</p><p>&bull; Voriconazole (a medicine used to treat fungal infections).</p><p>&bull; Phenytoin (a medicine used to treat seizures)</p><p>&bull; Colestipol/cholestyramine (used to lower cholesterol)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Zidovudine.</p><p>&nbsp;</p><p>Always tell your doctor or pharmacist about all the medicines you are taking. <em>This means</em></p><p><em>medicines you have bought yourself as well as medicines on prescription from your doctor.</em></p><p><strong>&nbsp;</strong></p><p><strong>d. </strong><strong>Pregnancy, breast-feeding </strong></p><p><strong>Pregnancy</strong></p><p>Do not take Voltaren Injections if you are in the last 3 months of pregnancy as it could harm your unborn child or cause problems at delivery. It can cause kidney and heart problems in your unborn baby. It may affect your and your baby&rsquo;s tendency to bleed and cause labour to be later or longer than expected. You should not take Voltaren Injections during the first 6 months of pregnancy unless absolutely necessary and advised by your doctor. If you need treatment during this period or while you are trying to get pregnant, the lowest dose for the shortest time possible should be used. If used for more than a few days from 20 weeks of pregnancy onward, Voltaren Injections can cause kidney problems in your unborn baby that may lead to low levels of amniotic fluid that surrounds the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the heart of the baby. If you need treatment for longer than a few days, your doctor may recommend additional monitoring.</p><p><s>&nbsp;</s></p><p>&bull; Are you trying for a baby? Having Voltaren Injections may make it more difficult to</p><p>conceive. You should talk to your doctor if you are planning to become pregnant, or if</p><p>you have problems getting pregnant.</p><p><strong>&nbsp;</strong></p><p><strong>e. </strong><strong>Driving and using machines</strong></p><p>Very occasionally people have reported that Voltaren Ampoules have made them feel dizzy, tired</p><p>or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you</p><p>should not drive or operate machinery.</p><p><strong>&nbsp;</strong></p><p><strong>Other special warnings</strong></p><p>&bull; You should take the lowest dose of Voltaren for the shortest possible time, particularly if</p><p>you are underweight or elderly.</p><p>&bull; There is a small increased risk of heart attack or stroke when you are taking any medicine</p><p>like Voltaren. The risk is higher if you are taking high doses for a long time. Always</p><p>follow the doctor&rsquo;s instructions on how much to take and how long to take it for.</p><p>&bull; If at any time while taking Voltaren you experience any signs or symptoms of problems</p><p>with your heart or blood vessels such as chest pain, shortness of breath, weakness, or</p><p>slurring of speech, contact your doctor immediately.</p><p>&bull; Whilst you are taking these medicines your doctor may want to give you a check-up from</p><p>time to time.</p><p>&bull; If you have a history of stomach problems when you are taking NSAIDs, particularly if</p><p>you are elderly, you must tell your doctor straight away if you notice any unusual</p><p>symptoms.</p><p>&bull; Because it is an anti-inflammatory medicine, Voltaren may reduce the symptoms of</p><p>infection, for example, headache and high temperature. If you feel unwell and need to see</p><p>a doctor, remember to tell him or her that you are taking Voltaren.</p><p>&bull; Voltaren Ampoules should not be used in children.</p><p>&nbsp;</p><p>Tell your doctor if you recently had or you are going to have a surgery of the stomach or</p><p>intestinal tract before taking Voltaren Ampoules, as Voltaren Ampoules can sometimes</p><p>worsen wound healing in your gut after surgery.</p><p>&nbsp;</p><p>Voltaren Ampoules contain propylene glycol, benzyl alcohol and sodium metabisulphite</p><p>This medicine contains 600mg propylene glycol per 3ml ampoule which is equivalent to 200mg/ml.</p><p>&nbsp;</p><p>This medicine contains 120mg benzyl alcohol per 3ml ampoule which is equivalent to 40mg/ml.&nbsp; Benzyl alcohol may cause allergic reactions.&nbsp; Ask your doctor or pharmacist for advice if you are pregnant or breast-feeding or if you have liver or kidney disease.&nbsp; This is because large amounts of benzyl alcohol can build up in your body and may cause side effects (called &lsquo;metabolic acidosis&rsquo;).</p><p>&nbsp;</p><p>Voltaren Ampoules contain the preservative, sodium metabisulphite. This can sometimes cause allergic reactions and breathing difficulties.</p><p>&nbsp;</p><p>Information about sodium content</p><p>This medicine contains less than 1mmol sodium (23mg) per 3ml ampoule, that is to say essentially &lsquo;sodium-free&rsquo;.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Your doctor will decide when and how to treat you with Voltaren Ampoules. You will either</p><p>be given an intravenous infusion (a drip into a vein) or an intramuscular injection (an injection</p><p>into a muscle). The intramuscular injection is usually injected into the buttocks.</p><p>&nbsp;</p><p>The usual dose is:</p><p><em>Adults</em></p><p>One or two ampoules (75 to 150 mg) each day for one or two days.</p><p><em>Elderly</em></p><p>Your doctor may give you a dose that is lower than the usual adult dose if you are elderly.</p><p><em>Children</em></p><p>Not suitable for children.</p><p>&nbsp;</p><p>A doctor, nurse or pharmacist will prepare the injection for you.</p><p>If you have had an operation and are in hospital, the ampoule contents may be diluted and put</p><p>into a drip bag before being given to you. A nurse or doctor will usually then give you the</p><p>injection or infusion. You would not usually have to give the injection to yourself.</p><p>&nbsp;</p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same</p><p>time, particularly if you have had stomach problems before, or if you are elderly, or taking</p><p>certain other drugs as well.</p><p><strong>&nbsp;</strong></p><p><strong>a. If you use more Voltaren Ampules than you should</strong></p><p>If you think you have been given too much Voltaren tell your doctor or nurse straight away.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Voltaren Ampoules are suitable for most people, but, like all medicines, they can sometimes cause</p><p>side effects. Side effects may be minimised by using the lowest effective dose for the shortest</p><p>duration necessary.</p><p><strong>&nbsp;</strong></p><p><strong>Some side effects can be serious</strong></p><p><strong>Tell the doctor straight away if you notice:</strong></p><p>&bull; Sudden and crushing chest pain (signs of myocardial infarction or heart attack)</p><p>&bull; Breathlessness, difficulty breathing when lying down, swelling of the feet or legs (signs of</p><p>heart failure)</p><p>&bull; Sudden weakness or numbness in the face, arm or leg especially on one side of the body;</p><p>sudden loss or disturbance of vision; sudden difficulty in speaking or ability to understand</p><p>speech; sudden migraine-like headaches which happen for the first time, with or without</p><p>disturbed vision. These symptoms can be an early sign of a stroke.</p><p>&bull; Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick)</p><p>&bull; Any sign of bleeding in the stomach or intestine, for example, when emptying your</p><p>bowels, blood in vomit or black, tarry faeces</p><p>&bull; Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling</p><p>or blistering</p><p>&bull; Wheezing or shortness of breath (bronchospasm)</p><p>&bull; Swollen, face, lips, hands or fingers</p><p>&bull; Yellowing of your skin or the whites of your eyes</p><p>&bull; Persistent sore throat or high temperature</p><p>&bull; An unexpected change in the amount of urine produced and/or its appearance.</p><p>&bull; Mild cramping and tenderness of the abdomen, starting shortly after the start of the</p><p>treatment with Voltaren Ampoules and followed by rectal bleeding or bloody diarrhoea</p><p>usually within 24 hours of the onset of abdominal pain.</p><p>&bull; Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis</p><p>syndrome.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Injection site reactions including injection site pain, redness, swelling, hard lump, sores and bruising. This can progress to blackening and death of the skin and underlying tissues surrounding the injection site, that heal with scarring, also known as Nicolau syndrome.</p><p>&nbsp;</p><p>If you notice that you are bruising more easily than usual or have frequent sore throats or</p><p>infections, tell your doctor.</p><p><strong>&nbsp;</strong></p><p><strong><u>The side effects listed below have also been reported.</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p>&bull; <strong>Common side effects </strong><strong><em>(These may affect between 1 and 10 in every 100 patients):</em></strong></p><p>Stomach pain, heartburn, nausea, vomiting, diarrhoea, indigestion, wind, loss of appetite</p><p>Headache, dizziness, vertigo</p><p>Skin rash or spots</p><p>Raised levels of liver enzymes in the blood</p><p>Injection site reactions, symptoms include redness, swelling, change in the skin colour,</p><p>inflammation, pain, and hypersensitivity</p><p>&nbsp;</p><p>&bull; <strong>Uncommon side effects (</strong><strong><em>These may affect between 1 and 10 in every 1000 patients)</em></strong><strong>:</strong></p><p>Fast or irregular heart beat (palpitations), chest pain, heart disorders, including heart attack or</p><p>breathlessness, difficulty breathing when lying down, or swelling of the feet or legs (signs of</p><p>heart failure), especially if you have been taking a higher dose (150 mg per day) for a long</p><p>period of time.</p><p>&nbsp;</p><p>&bull; <strong>Rare side effects </strong><em>(</em><strong><em>These may affect between 1 in every 1000 to 1 in every 10,000 patients):</em></strong></p><p>Stomach ulcers or bleeding (there have been very rare reported cases resulting in death,</p><p>particularly in the elderly)</p><p>Gastritis (inflammation, irritation or swelling of the stomach lining)</p><p>Vomiting blood</p><p>Diarrhoea with blood in it or bleeding from the back passage</p><p>Black, tarry faeces or stools</p><p>Drowsiness, tiredness</p><p>Skin rash and itching</p><p>Fluid retention, symptoms of which include swollen ankles</p><p>Liver function disorders, including hepatitis and jaundice</p><p>Asthma (symptoms may include wheezing, breathlessness, coughing and a tightness across the</p><p>chest)</p><p>&bull; <strong>Very rare side effects (</strong><strong><em>These may affect less than 1 in every 10,000 patients):</em></strong></p><p><u>Effects on the nervous system:</u></p><p>Inflammation of the lining of the brain (meningitis), Tingling or numbness in the fingers,</p><p>tremor, visual disturbances such as blurred or double vision, hearing loss or impairment,</p><p>tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety,</p><p>irritability, mental disorders, disorientation and loss of memory, fits, headaches together with</p><p>a dislike of bright lights, fever and a stiff neck.</p><p>&nbsp;</p><p><u>Effects on the stomach and digestive system:</u></p><p>Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the</p><p>mouth or lips, lower gut disorders (including inflammation of the colon, or worsening of colitis</p><p>or Crohn&rsquo;s disease), inflammation of the pancreas.</p><p>&nbsp;</p><p><u>Effects on the chest or blood:</u></p><p>hypertension (high blood pressure), hypotension (low blood pressure, symptoms of which may</p><p>include faintness, giddiness or light headedness), inflammation of blood vessels (vasculitis),</p><p>inflammation of the lung (pneumonitis), blood disorders (including anaemia).</p><p>&nbsp;</p><p><u>Effects on the liver or kidneys:</u></p><p>Kidney or severe liver disorders including liver failure, presence of blood or protein in the</p><p>urine.</p><p>&nbsp;</p><p><u>Effects on skin or hair:</u></p><p>Facial swelling, Serious skin rashes including Stevens-Johnson syndrome, Lyell&rsquo;s syndrome and</p><p>other skin rashes which may be made worse by exposure to sunlight. Injection site abscess.</p><p>Hair loss.</p><p>&nbsp;</p><p><u>Effects on the reproductive system:</u></p><p>Impotence.</p><p>&nbsp;</p><p><u>Other side effects that have also been reported include:</u></p><p>Throat disorders, confusion, hallucinations, malaise (general feeling of</p><p>discomfort), inflammation of the nerves in the eye, tissue damage at the injection site.</p><p><strong>&nbsp;</strong></p><p><strong>Do not be alarmed by this list - most people have an injection of </strong><strong>Voltaren </strong><strong>without any</strong></p><p><strong>problems.</strong></p><p><strong>&nbsp;</strong></p><p><strong>If any of the symptoms become troublesome, or if you notice anything else not mentioned here,</strong></p><p><strong>please go and see your doctor. your doctor may want to give you a different medicine.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&deg;C. Protect from light and heat.</p><p>Keep out of the reach and sight of children.</p><p>Do not use Voltaren Ampoules after the expiry date which is printed on the outside of the pack.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The glass ampoules contain 75 mg of the active ingredient, diclofenac sodium, in solution.</p><p>The ampoules also contain mannitol, sodium metabisulphite (E223), benzyl alcohol, propylene glycol, sodium hydroxide, water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Voltaren Ampoules come in packs of 5.  
not all pack sizes may be marketed.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG.</p><p>www.Novartis.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02/2023

e. To report any side effect(s):
•	Saudi Arabia

The National Pharmacovigilance Centre (NPC):

o Fax: +966-11-205-7662
o SFDA call center: 19999
o E-mail: npc.drug@sfda.gov.sa
o Website: https://ade.sfda.gov.sa 

Patient Safety Department Novartis Consulting AG - Saudi Arabia:
o Toll Free Number: 8001240078
o Phone: +966112658100 
o Fax: +966112658107
o Email: adverse.events@novartis.com  

•    Other GCC States:
-  Please contact the relevant competent authority.

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يُعتبر ديكلوفيناك الصوديوم، المادة الفعالة في عقار فولتارين أمبولات، واحدًا من مجموعة أدوية تُسَمَّى مضادات الالتهاب غير الستيرويدية.&nbsp; وتعمل مضادات الالتهاب غير الستيرويدية على تقليل الألم والالتهاب.&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يُستخدم الحقن العضلي لعلاج عدد من حالات الألم بما في ذلك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &quot;نوبات احتدام&quot; المفاصل أو ألم الظهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات النّقْرِس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم نتيجة حصى الكلى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم نتيجة الإصابات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستخدم فولتارين للتسريب الوريدي في الوريد لعلاج أو منع الألم بعد الجراحة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن إعطاء عقار فولتارين أمبولات إما في صورة حقن في العضل، أو في صورة تسريب بطيء في الوريد.&nbsp; ويستخدم التسريب الوريدي في المستشفيات لمنع حدوث الألم &nbsp;أو علاجه بعد إجراء العمليات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يُعد عقار فولتارين أمبولات غير مناسب للأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>موانع استعمال </strong><strong>عقار فولتارين أمبولات.</strong></p><p dir="RTL"><strong>تحدَّث إلى طبيبك في الحالات الآتية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعتقد أنك قد تكون لديك حساسية تجاه ديكلوفيناك الصوديوم أو صوديوم ميتابيسلفيت أو الأَسْبِرين أو الإيبوبروفين أو أي من مضادات الالتهاب غير الستيرويدية الأخرى أو أيٍّ من المكونات الأخرى بعقار فولتارين أمبولات.&nbsp; (وهذه المكونات مدرجة في نهاية النشرة).&nbsp; تتضمن علامات تفاعل فرط الحساسية تورم الوجه والفم (وَذَمَة وِعائِيَّة)، مشاكل التَّنفس، سيلان الأنف، طفحًا جلديًّا أو أي نوع من أنواع تفاعلات فرط الحساسية الأخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني حاليًا أو قد عانيت من قبل من قرحة بالمعدة أو بالإثنا عشر (هضمية)، أو نزيف بالجهاز الهضمي (يمكن أن يتضمن ذلك، تقيؤًا دمويًّا، نزيفًا عند إفراغ الأمعاء، خروج دم صافٍ في البراز أو خروج براز أسود قطراني اللون).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت من مشاكل بالمعدة أو الأمعاء بعد تناول مضادات الالتهاب غير الستيرويدية الأخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فشل في الكبد أو الكلى أو قصور عضلة القلب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض مثبت بالأوعية الدَّموية بالمخ و/ أو مرض بالقلب على سبيل المثال: إذا كنت قد أصبت بنوبة قلبية، سكتة دماغية، سكتة دماغية صغرى (نوبة إقفارية عابرة) أو انسداد بالأوعية الدَّموية الواصلة إلى القلب أو المخ أو كنت قد خضعت لعملية لإزالة انسداد مجرى الأوعية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو قد عانيت من مشاكل بالدَّورة الدَّموية لديك (مرض الشرايين الطرفية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملًا لأكثر من ستة أشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ب&zwnj;. </strong><strong>الاحتياطات عند استعمال عقار فولتارين أمبولات.</strong></p><p dir="RTL"><strong>يجب أيضًا أن تسأل نفسك هذه الأسئلة قبل استخدام عقار فولتارين أمبولات:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تعاني من أية اضطرابات بالأمعاء بما في ذلك، التهاب القولون التقرحي أو مرض كرون؟</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تعاني من مشاكل في الكلى أو الكبد؟ أو هل أنت من كبار السن؟</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تعاني من أي اضطراب بالدَّم أو اضطراب نزفي؟</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تعاني من حالة مرضية تُسمى البُرْفيرِيَّة؟</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل عانيت من قبل من الربو؟</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل أنتِ مرضعًا؟</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تعاني من ذبحة صدرية، جلطات دموية، ارتفاع ضغط الدَّم، ارتفاع غير طبيعي في بمستوى الدهون في الدم (زيادة الكوليسترول أو زيادة الدهون الثلاثية)؟</p><ul><li dir="RTL">هل تعاني من مشاكل في القلب، أو تعرضت من قبل&nbsp; لسكتة دماغية؟ أو هل تظن أنك قد تكون معرضًا لخطر الإصابة بهذه الحالات (على سبيل المثال: إذا كنت تعاني من ارتفاع ضغط الدَّم، أو السكري، أو ارتفاع الكوليسترول أو كنت مدخنًا)؟</li><li dir="RTL">هل تعاني من مرض السكري؟</li><li dir="RTL">هل أنت مدخن؟</li><li dir="RTL">هل تعاني من الذئبة الحمراء أو أي حالة مرضية مشابهة؟</li><li dir="RTL">هل من الممكن أن تعاني من الجفاف؟</li><li dir="RTL">هل عانيت من أي فقدان غزير للدَّم مؤخرًا؟</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كانت الإجابة على أي من هذه الأسئلة بنعم، فتناقش مع طبيبك أو الصيدلي الخاص بك بخصوص علاجك؛ حيث قد لا يكون عقار</strong><strong>فولتارين</strong> <strong>أمبولات هو الدَّواء الصحيح بالنسبة لك.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>ج. التداخلات الدوائية من أخذ عقار فولتارين أمبولات&nbsp; مع أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">يمكن أن تتداخل بعض الأدوية مع علاجك.&nbsp; أخبر طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أيًّا من الأدوية التَّالية:</p><ul><li dir="RTL">أدوية لعلاج مرض السُّكَّرِي.</li><li dir="RTL">مضادات التجلط (أقراص سيولة الدَّم مثل: وارفارين).</li><li dir="RTL">مدرات البول (أقراص الماء).</li><li dir="RTL">الليثيوم (يُستخدم لعلاج بعض المشاكل الذهنية).</li><li dir="RTL">ميثوتريكسات (لعلاج بعض الأمراض الالتهابية وبعض السرطانات).</li><li dir="RTL">سيكلوسبورين وتاكروليمس (يُستخدمان لعلاج بعض الأمراض الالتهابية وبعد عمليات زرع الأعضاء).</li><li dir="RTL">ترايميثوبريم (دواء يستَخدَم للوقاية من عدوى المسالك البولية أو لعلاجها).</li><li dir="RTL">المضادات الحيوية من مجموعة الكينولون (لعلاج العدوى).</li><li dir="RTL">أي من مضادات الالتهاب غير الستيرويدية أو مثبطات الأكسدة الحلقية-2 الأخرى، على سبيل المثال: الأسبرين أو الإيبوبروفين.</li><li dir="RTL">ميفيبريستون (دواء يستخدم لإنهاء الحمل).</li><li dir="RTL">الجليكوزيدات القلبية (على سبيل المثال: ديجوكسين)، تستخدم لعلاج مشاكل القلب.</li><li dir="RTL">أدوية تعرف باسم مثبطات إعادة امتصاص السيروتونين الانتقائية والتي تستخدَم لعلاج الاكتئاب.</li><li dir="RTL">الستيرويدات التي تؤخذ عن طريق الفم (إحدى العقاقير المضادة للالتهابات).</li><li dir="RTL">أدوية تُستخدم لعلاج الحالات المرضية القلبية أو ارتفاع ضغط الدَّم، على سبيل المثال: حاصرات بيتا أو مُثبطات إنزيم تحويل الأنجيوتنسين.</li><li dir="RTL">فوريكونازول (أحد الأدوية التي تُستخدم لعلاج الالتهابات الفطرية).</li><li dir="RTL">فينيتوين (أحد الأدوية التي تستخدم لعلاج<strong> </strong>النوبات التشنجية).</li><li dir="RTL">كوليستيبول/ كولستيرامين (يُستخدَم لخفض&nbsp; الكوليسترول).</li><li dir="RTL">زيدوفودين.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي الخاص بك دائمًا بكل الأدوية التي تتناولها.&nbsp; <em>ويعني هذا الأدوية التي اشتريتها بنفسك والأدوية التي اشتريتها بوصفة طبية من طبيبك.</em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>د. </strong><strong>الحمل والرضاعة </strong></p><p dir="RTL"><strong>الحمل </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تأخذي عقار فولتارين للحقن إذا كنتِ في الأشهر الثلاثة الأخيرة من الحمل لأنها قد تضر بجنينك أو تسبب مشاكل عند الولادة. يمكن أن يسبب مشاكل في الكلى والقلب لجنينك الذي لم يولد بعد. قد يؤثر على قابليتكِ و طفلك للنزيف ويتسبب في تأخر المخاض أو تأخره عن المتوقع. لا يجب أن تأخذي عقار فولتارين للحقن خلال الأشهر الستة الأولى من الحمل ما لم يكن ذلك ضروريًا للغاية ونصحك طبيبك. إذا كنت بحاجة إلى علاج خلال هذه الفترة أو أثناء محاولتك الحمل ، فيجب استخدام أقل جرعة لأقصر وقت ممكن. إذا تم استخدام عقار فولتارين للحقن لأكثر من بضعة أيام من الأسبوع 20 من الحمل فصاعدًا ، يمكن أن يسبب ذلك مشاكل في الكلى لطفلك الذي لم يولد بعد والذي قد يؤدي إلى انخفاض مستويات السائل الأمنيوسي الذي يحيط بالطفل (قلة السائل السلوي) أو تضيق الأوعية الدموية (القناة الشريانية) في قلب الطفل. إذا كنت بحاجة إلى علاج لمدة تزيد عن بضعة أيام ، فقد يوصي طبيبك بمراقبة إضافية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هل تحاولين الإنجاب؟&nbsp; قد يجعل استخدام عقار فولتارين للحقن حدوث الحمل أكثر صعوبة.&nbsp; يجب عليكِ إخبار طبيبك إذا كنتِ تخططين للحمل أو إذا كان لديكِ مشاكل في أن تصبحي حاملًا.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>هـ. </strong><strong>تأثير عقار فولتارين أمبولات على القيادة واستخدام الآلات</strong></p><p dir="RTL">أفاد أشخاص بأنَّ استخدام عقار فولتارين أمبولات جعلهم يشعرون بدوخة أو إجهاد أو نعاس في كثير من الأحيان.&nbsp; وتم أيضًا الإبلاغ عن حدوث مشاكل في الإبصار.&nbsp; إذا تأثرت بهذه الطريقة، فيجب عدم ممارسة القيادة أو تشغيل&nbsp; الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>و. معلومات هامة حول بعض مكونات عقار فولتارين أمبولات </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي عقار فولتارين أمبولات على المادة الحافظة صوديوم ميتابيسلفيت.&nbsp; ومن الممكن أن يُسبب ذلك في بعض الأحيان تفاعلات حساسية وصعوبات في التنفس.</p><p dir="RTL">&nbsp;</p><p>تحذيرات خاصَّة أخرى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب أن تستخدم أقل جرعة من عقار فولتارين لأقصر وقت ممكن، خاصَّة إذا كنت تعاني من نقص الوزن أو كنت من كبار السن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هناك زيادة بسيطة في خطر حدوث نوبة قلبية أو سكتة دماغية عند استخدام أي دواء مثل عقار فولتارين.&nbsp; ويزداد الخطر في حالة استخدام جرعات عالية لوقت طويل.&nbsp; اتبع دائمًا تعليمات الطبيب بخصوص كمية الدَّواء والمدة اللازمة لاستخدامه.</p><ul><li dir="RTL">إذا واجهت في أي وقت أثناء استعمال عقار فولتارين، أي علامات أو أعراض لمشاكل في القلب أو الأوعية الدموية مثل آلام الصدر ، ضيق في التنفس ، ضعف ، أو اهتزاز الكلام ، اتصل بطبيبك على الفور.</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ربما يرغب طبيبك أثناء استخدامك لهذه الأدوية في إجراء فحص لك من حين لآخر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تاريخ سابق من الإصابة بمشاكل في المعدة أثناء تناول مضادات الالتهاب غير الستيرويدية، خاصَّة إذا كنت من كبار السن، فيجب أن تقوم بإبلاغ طبيبك فورًا إذا لاحظت حدوث أي أعراض غير معتادة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نظرًا لأن عقار فولتارين أحد الأدوية المضادة للالتهاب، فقد يقلل حدوث أعراض العدوى، على سبيل المثال: الصداع وارتفاع درجة الحرارة.&nbsp; إذا شعرت بأنك لست على ما يرام وبحاجة إلى زيارة الطبيب، فتذكر أن تخبره بأنك تستخدم عقار فولتارين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب أَلَّا يستخدم عقار فولتارين أمبولات في الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك قبل أن تستعمل أمبولات فولتارين إذا كنت قد أجريت مؤخرًا أو ستخضع لعملية جراحية في المعدة أو الأمعاء. حيث أن أمبولات فولتارين يمكن أن تؤدي أحيانًا إلى تفاقم التئام الجروح في أمعائك بعد الجراحة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحتوي أمبولات فولتارين على بروبيلين جليكول وكحول بنزيل وميتابيسلفيت الصوديوم</p><p dir="RTL">يحتوي هذا الدواء على 600 مجم بروبيلين جليكول لكل أمبولة 3 مل أي ما يعادل 200 مجم / مل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا الدواء على 120 ملغ من كحول بنزيل لكل أمبولة 3 مل أي ما يعادل 40 ملغ / مل. قد يسبب كحول البنزيل ردود فعل تحسسية. اسألي طبيبك أو الصيدلي للحصول على المشورة إذا كنت حاملا أو مرضعة أو إذا كنت تعانين من أمراض الكبد أو الكلى. وذلك لأن كميات كبيرة من كحول البنزيل يمكن أن تتراكم في جسمك وقد تسبب آثارًا جانبية (تسمى &quot;الحماض الأيضي&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحتوي أمبولات فولتارين على مادة حافظة، ميتابيسلفيت الصوديوم. يمكن أن يسبب هذا في بعض الأحيان ردود فعل تحسسية وصعوبات في التنفس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">معلومة عن محتوى الصوديوم:</p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 مليمول صوديوم (23 ملغ) لكل 3 مل أمبولة ، وهذا يعني بشكل أساسي &quot;خالٍ من الصوديوم&quot;.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيقرر طبيبك توقيت وكيفية علاجك بعقار فولتارين أمبولات. وسيتم إعطاؤك إما التسريب الوريدي (التقطير بداخل الوريد) أو الحقن العضلي (حقنة بداخل العضل). عادةً ما يتم حقن الحقنة العضلية في الأرداف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعة المعتادة هي:</p><p dir="RTL"><em>البالغون</em></p><p dir="RTL">أمبولة واحدة أو أمبولتان (75 إلى 150 مجم) كل يوم لمدة يوم واحد أو يومين.&nbsp;</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>المرضى من كبار السن</em></p><p dir="RTL">ربما يعطيك طبيبك جرعة أقل من جرعة البالغين المعتادة إذا كنت من كبار السن.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الأطفال</em></p><p dir="RTL">غير مناسب للأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيقوم الطبيب أو الممرض أو الصيدلي بتحضير الحقنة لك.</p><p dir="RTL">إذا كنت قد خضعت لإجراء عملية وكنت مودعًا بالمستشفى، فمن الممكن أن يتم تخفيف محتويات الأمبول ووضعه في كيس تقطير قبل إعطائه لك. وعادةً سيقوم الممرض أو الطبيب بعد ذلك بإعطائك الحقنة أو التَّسريب. ولا ينبغي عادة أن تعطي الحقنة لنفسك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يصف الطبيب أيضًا عقارًا آخر لحماية المعدة يتم تناوله في الوقت نفسه، خاصَّة إذا كنت قد عانيت من قبل من مشاكل في المعدة، أو إذا كنت من كبار السن، أو إذا كنت تتناول بعض العقاقير الأخرى كذلك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الجرعة الزائدة من عقار فولتارين أمبولات </strong></p><p dir="RTL">إذا كنت تعتقد أنه قد تم إعطاؤك عقار فولتارين بكمية أكبر مما يجب، فيُرجى إخبار طبيبك أو الممرض الخاص بك فورًا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">عقارفولتارين أمبولات مناسب لمعظم الأشخاص، ولكن مثله مثل كل الأدوية، قد يُسبب أعراض جانبية في بعض الأحيان.&nbsp; يُمكِن تقليل الأعراض الجانبيَّة باستخدام أقل جرعة فعَّالة لأقصر مدة ضرورية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>بعض الأعراض الجانبية قد تكون خطيرة</u></strong></p><p dir="RTL"><strong>أخبر الطبيب على الفور إذا لاحظت:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم مفاجئ وساحق في الصدر (علامات احتشاء عضلة القلب أو النوبة القلبية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس ، وصعوبة في التنفس عند الاستلقاء وتورم القدمين أو الساقين (علامات قصور عضلة القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف أو خدر مفاجئ في الوجه والذراع أو الساق خاصة على جانب واحد من الجسم. فقدان مفاجئ أو اضطراب في الرؤية ؛ صعوبة مفاجئة في التحدث أو القدرة على فهم الكلام ؛ صداع مفاجئ يشبه الصداع النصفي يحدث لأول مرة ، مع أو بدون رؤية مضطربة. يمكن أن تكون هذه الأعراض علامة مبكرة على السكتة الدماغية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالمعدة، عسر هضم، حموضة (حُرْقَة المعدة)، خروج ريح، غثيان (شعور بالإعياء) أو قيئ (إعياء).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي علامة على وجود نزيف في المعدة أو الأمعاء، على سبيل المثال: عند إفراغ أمعائك، وجود دم في القيء أو إخراج براز بلون أسود أو قطراني.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية والتي قد تتضمن طفحًا جلديًّا، حكة، كدمات، مناطق حمراء مؤلمة، تقشرًا أو بثور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صفير بالصدر أو ضيق التَّنفس (ضيق الشعب الهوائية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه أو الشفتين أو اليدين أو أصابع اليدين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو الأجزاء البيضاء في عينيك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب مستمر في الحلق أو ارتفاع درجة الحرارة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيير غير متوقع في كمية البول الناتج و/ أو شكله.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أوجاع وتقلصات طفيفة في البطن، تبدأ بعد وقت قصير من بدء العلاج بعقار فولتارين أمبولات ويليها حدوث نزيف من المستقيم أو إسهال دموي عادة خلال 24 ساعة من بداية حدوث ألم البطن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر ، والذي يمكن أن يكون علامة على رد فعل تحسسي خطير محتمل يسمى متلازمة كونيس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات موقع الحقن بما في ذلك ألم موقع الحقن ، احمرار ، تورم ، كتلة صلبة ، تقرحات وكدمات. يمكن أن يتطور هذا إلى اسوداد وموت الجلد والأنسجة الكامنة المحيطة بموقع الحقن ، والتي تلتئم بالتندب ، المعروف أيضًا باسم متلازمة نيكولاو.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لاحظت أنك تصاب بكدمات بسهولة أكبر من المعتاد أو تعاني من الإصابة بالتهاب متكرر في الحلق أو بالعدوى المتكررة، فأخبر طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>تم أيضًا الإبلاغ عن الأعراض الجانبية المدرجة أدناه.</u></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأعراض الجانبية الشَّائعة<em> (قد تؤثر في ما بين 1 و 10 في كل 100 مريض): </em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالمعدة، حموضة (حُرْقَة المعدة)، غثيان، قيء، إسهال، عسر هضم، غازات، فقدان الشهية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; صداع، دوخة، دوار.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أو بقع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في مستويات إنزيمات الكبد بالدَّم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات بموضع الحقن، أعراض تتضمن احمرارًا وتورمًا وتغيرًا في لون الجلد والتهابًا وألمًا وفرط الحساسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأعراض الجانبية غير الشائعة <em>(قد تؤثر في ما بين 1 و 10 في كل 1000 مريض):</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; سرعة أو عدم انتظام ضربات القلب (الخفقان) ، ألم في الصدر ، واضطرابات في القلب ، بما في ذلك النوبة القلبية أو ضيق التنفس ، صعوبة التنفس عند الاستلقاء ، أو تورم القدمين أو الساقين (علامات قصور عضلة القلب) ، خاصة إذا كنت تتناول جرعة أعلى (150 مجم في اليوم) لفترة طويلة من الزمن.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأعراض الجانبيَّة النادرة<em> (قد تؤثر في ما بين 1 في كل 1000 إلى 1 في كل 10000 مريض):</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; نزيف أو قرح بالمعدة (تم الإبلاغ عن تسبب حالات نادرة جدًّا في حدوث الوفاة، خاصَّة في المرضى كبار السن).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المعدة (التهاب، تهيج أو تورم بطانة المعدة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; قيء دموي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إسهال به دم أو نزيف من المستقيم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; خروج براز أسود قطراني اللون.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; نعاس، تعب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي وحكة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; احتباس السوائل، تتضمن أعراضها تورم الكاحلين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بوظائف الكبد، بما في ذلك التهاب الكبد واليرقان (الاصفرار).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الربو (قد تشمل الأعراض الصفير ، ضيق التنفس ، السعال والضيق في جميع أنحاء الصدر)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; نخر بموضع الحقن (موت الجلد والنسيج حول موضع الحَقن).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأعراض الجانبيَّة النَّادرة جدًّا<em> (قد تُؤثر في أقل من 1 في كل 10000 مريض):</em></strong></p><p dir="RTL"><u>الأعراض على الجهاز العصبي:</u></p><p dir="RTL">التهاب بطانة المخ (التهاب السحايا) ، تنميل أو وخز في أصابع اليدين، ارتعاش، اضطرابات بصرية مثل: ازدواج الرؤية أو عدم وضوحها، فقدان حاسة السمع أو ضعفها، طنين بالأذن، عدم القدرة على النوم (أرق)، كوابيس، تغيرات في المزاج، اكتئاب، قلق، تهيج، اضطرابات ذهنية، تَوَهان وفقدان الذاكرة، نوبات تشنج، صداع مصحوب بنفور من الأضواء الساطعة، حمى وتصلب الرقبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض على المعدة والجهاز الهضمي:</u></p><p dir="RTL">إمساك، التهاب اللسان، قرح بالفم، التهاب بداخل الفم أو الشفتين ، اضطرابات الأمعاء السفلية (بما في ذلك، التهاب القولون، أو تدهوره أو مرض كرون)، التهاب البنكرياس.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض على الصدر أو الدَّم:</u></p><p dir="RTL">ارتفاع ضغط الدَّم، انخفاض ضغط الدم (انخفاض ضغط الدم ، وقد تشمل أعراضه الإغماء أو الدوخة أو الدوار) ،التهاب الأوعية الدَّموية، التهاب رئوي، اضطرابات الدَّم (بما في ذلك، فقر الدَّم).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض على الكبد أو الكُلى:</u></p><p dir="RTL">اضطرابات شديدة بالكبد أو الكُلى بما في ذلك، الفشل الكبدي، وجود دم أو بروتين في البول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض على الجلد أو الشعر:</u></p><p dir="RTL">تورم الوجه، طفح جلدي خطير يشمل متلازمة ستيفنز جونسون، متلازمة لايل وغيره من الطفح الجلدي الذي قد يتدهور عند التعرض لأشعة الشمس، خراج موقع الحقن.</p><p dir="RTL">تساقط الشعر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض على الجهاز التناسلي:</u></p><p dir="RTL">ضعف جنسي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>ومن الأعراض الجانبية الأخرى التي تم الإبلاغ عنها أيضًا ما يلي:</u></p><p dir="RTL">خراج في موضع الحقن، اضطرابات الحلق، ارتباك/ التباس، هلوسة، توعك (شعور عام بعدم الراحة)، التهاب الأعصاب في العينين، تلف النسيج في موضع الحَقن.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>لا تقلق من قائمة الأعراض الجانبية هذه - فمعظم الأشخاص يستخدمون حقن عقار فولتارين بدون أي مشاكل.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أصبح أي من الأعراض مزعجًا، أو إذا لاحظت أيَّ شيء آخر غير مدرج في هذه النَّشرة، فيُرجى الذهاب إلى طبيبك واستشارته.</strong> <strong>&nbsp;ربما يرغب الطبيب في إعطائك دواءً مختلفًا.</strong><strong> </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفَظ في درجة حرارة أقل من 30 درجة مئوية.&nbsp; يجب حماية هذا العقار من الضوء والحرارة.</p><p dir="RTL">يحفظ بعيدًا عن متناول ورؤية الأطفال.</p><p dir="RTL">لا تستخدم عقار فولتارين أمبولات بعد انتهاء تاريخ الصلاحية المطبوع على الجزء الخارجي من العبوة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحتوي الأمبولات الزجاجية على 75 مجم من المادة الفعالة ديكلوفيناك الصوديوم في محلول.&nbsp;&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحتوي الأمبولات أيضًا على مانِّيتول، صوديوم ميتابيسلفيت (E223)، كحول بنزيلي، بروبيلين جليكول، هيدروكسيد الصوديوم، ماء.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر عقار فولتارين أمبولات في عبوات بكل منها5 أمبولات.</p><p dir="RTL">قد لا تكون جميع أحجام العبوات متوفرة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك حق التسويق لهذا المنتج هي شركة نوفارتس فارما إيه جي.</p><p dir="RTL">www.Novartis.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2/2023

هـ.  للإبلاغ عن الأعراض الجانبية : 
•	المملكة العربية السعودية

   - المركز الوطني للتيقظ والسلامة الدوائية (NPC)
•	الفاكس: +966-11-205-7662
•	مركز اتصال الهيئة السعودية للغذاء والدواء: 19999
•	البريد الالكتروني: npc.drug@sfda.gov.sa
•	الموقع الالكتروني: https://ade.sfda.gov.sa

-	شركة نوفارتس - السعودية - قسم سلامة المرضى:
•	الهاتف المجاني: 8001240078
•	الهاتف:  +966112658100
•	الفاكس: +966112658107
•	البريد الالكتروني: adverse.events@novartis.com

•	دول مجلس التَّعاون الخليجي الأخرى: 
- يُرجى الاتصال بسلطات الاختصاص المعنية

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Voltaren® Ampoules 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate) (diclofenac sodium).
Each 3ml ampoule contains 75mg diclofenac sodium Ph.Eur.	
Excipients(s) with known effect
Propylene glycol, benzyl alcohol, sodium metabisulphite.  
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection in ampoules.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Ampoules for im use</em>:</p><p>The ampoules are effective in acute forms of pain, including renal colic, exacerbations of osteo- and rheumatoid arthritis, acute back pain, acute gout, acute trauma and fractures, and post-operative pain.</p><p><em>Ampoules used in intravenous infusion</em>:</p><p>For treatment or prevention of post-operative pain in the hospital setting.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4 Special warnings and precautions for use).</p><p><strong>Adults</strong></p><p>Voltaren ampoules (given im or iv) should not be given for more than two days; if necessary, treatment can be continued with Voltaren tablets or suppositories.</p><p>Intramuscular injection: The following directions for intramuscular injection must be adhered to in order to avoid damage to a nerve or other tissue at the injection site.</p><p>One ampoule once (or in severe cases twice) daily intramuscularly by deep intragluteal injection into the upper outer quadrant.&nbsp; If two injections daily are required it is advised that the alternative buttock be used for the second injection.&nbsp; Alternatively, one ampoule of 75mg can be combined with other dosage forms of Voltaren (tablets or suppositories) up to the maximum daily dosage of 150mg.&nbsp;</p><p>Renal colic:&nbsp; One 75mg ampoule intramuscularly.&nbsp; A further ampoule may be administered after 30 minutes if necessary.&nbsp; The recommended maximum daily dose of Voltaren is 150mg.</p><p><em>Intravenous Infusion</em>:&nbsp; Immediately before initiating an intravenous infusion, Voltaren must be diluted with 100-500ml of either sodium chloride solution (0.9%) or glucose solution (5%).&nbsp; Both solutions should be buffered with sodium bicarbonate solution (0.5ml 8.4% or 1ml 4.2%).&nbsp; Only clear solutions should be used.&nbsp;&nbsp;&nbsp;</p><p>Voltaren must not be given as an intravenous bolus injection.</p><p>Two alternative regimens are recommended:</p><p>For the<em> treatment</em> of moderate to severe post-operative pain, 75mg should be infused continuously over a period of 30 minutes to 2 hours.&nbsp; If necessary, treatment may be repeated after 4-6 hours, not exceeding 150mg within any period of 24 hours.</p><p>For the <em>prevention</em> of post-operative pain, a loading dose of 25mg-50mg should be infused after surgery over 15 minutes to 1 hour, followed by a continuous infusion of approx. 5mg per hour up to a maximum daily dosage of 150mg.</p><p><strong>Special populations</strong></p><p><strong>Elderly</strong></p><p>Although the pharmacokinetics of Voltaren are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in such patients who generally are more prone to adverse reactions.&nbsp; In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight (see also Precautions) and the patient should be monitored for GI bleeding during NSAID therapy.</p><p><strong>Cardiovascular and significant cardiovascular risk factors</strong></p><p>Diclofenac is contraindicated in patients with established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease (see section 4.3 Contraindications).</p><p>Patients with congestive heart failure (NYHA-I) or significant risk factors for cardiovascular disease should be treated with diclofenac only after careful consideration. Since cardiovascular risks with diclofenac may increase with dose and duration of exposure, the lowest effective daily dose should be used and for the shortest duration possible (see section 4.4 Special warnings and precautions for use).</p><p><strong>Renal impairment</strong></p><p>Diclofenac is contraindicated in patients with renal failure (see section 4.3 Contraindications).&nbsp;</p><p>No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering diclofenac to patients with mild to moderate renal impairment (see section 4.4 Special warnings and precautions for use).</p><p><strong>Hepatic impairment</strong></p><p>Diclofenac is contraindicated in patients with hepatic failure (see section 4.3 Contraindications).&nbsp;</p><p>No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering diclofenac to patients with mild to moderate hepatic impairment (see section 4.4 Special warnings and precautions for use).</p><p><strong>Paediatric population</strong></p><p>Voltaren ampoules are not recommended for use in children.</p><p>The recommended maximum daily dose of Voltaren is 150mg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the active substance, sodium metabisulphite or any of the excipients.
•	Active, gastric or intestinal ulcer, bleeding or perforation 
•	History of gastrointestinal bleeding or perforation, relating to previous NSAID therapy
•	Active, or history of recurrent peptic ulcer/haemorrhage  (two or more distinct episodes of proven ulceration or bleeding)
•	Last trimester of pregnancy (see section 4.6 Fertility, pregnancy and lactation)
•	Hepatic failure
•	Renal failure
•	Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease
•	Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.
Specifically for iv use.
•	Concomitant NSAID or anticoagulant use (including low dose heparin). 
•	History of haemorrhagic diathesis, a history of confirmed or suspected cerebrovascular bleeding. 
•	Operations associated with a high risk of haemorrhage. 
•	A history of asthma. 
•	Moderate or severe renal impairment (serum creatinine >160*mol/l).
•	Hypovolaemia or dehydration from any cause. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 Posology and method of administration and GI and cardiovascular risks below.)</p><p>The concomitant use of Voltaren with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5 Interactions with other medicinal products and other forms of interaction).</p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight (see section 4.2 Posology and method of administration).</p><p>As with other nonsteroidal anti-inflammatory drugs including diclofenac, allergic reactions, including anaphylactic/anaphylactoid reactions can also occur without earlier exposure to the drug (see section 4.8 Undesirable effects).&nbsp;</p><p>Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction.&nbsp; Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to diclofenac.</p><p>&nbsp;</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of the infection due to its pharmacodynamic properties.</p><p>The instructions for intramuscular injection should be strictly followed in order to avoid adverse events at the injection site, which may result in muscle weakness, muscle paralysis, hypoaesthesia, embolia cutis medicamentosa (Nicolau syndrome) and injection site necrosis.</p><p><strong>Gastrointestinal effects:</strong></p><p>Gastrointestinal bleeding<strong> </strong>(haematemesis, melaena), ulceration or perforation which can be fatal has been reported with all NSAIDs including diclofenac<em> </em>and may occur at any time during treatment, with or without warning symptoms or a previous history of serious GI events. They generally have more serious consequences in the elderly.&nbsp; If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the drug should be withdrawn.</p><p>As with all NSAIDs<strong>, </strong>including diclofenac<strong>, </strong>close medical surveillance is imperative and particular caution should be exercised when prescribing diclofenac in patients with symptoms indicative of gastrointestinal disorders, or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8 Undesirable effects).&nbsp; The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses including diclofenac, and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation.</p><p>The elderly have increased frequency of adverse reactions to NSAIDs especially gastro intestinal bleeding and perforation which may be fatal (see section 4.2 Posology and method of administration).</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low dose acetylsalicylic acid (ASA/aspirin or medicinal products likely to increase gastrointestinal risk. (See section 4.5 Interactions with other medicinal products and other forms of interaction).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding).</p><p>Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5 Interaction with other medicinal products and other forms of interaction).</p><p>Close medical surveillance and caution should be exercised in patients with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8 Undesirable effects).</p><p>NSAIDs, including diclofenac, may be associated with increased risk of gastro-intestinal anastomotic leak.&nbsp; Close medical surveillance and caution are recommended when using diclofenac after gastro-intestinal surgery.</p><p><strong>Hepatic effects:</strong></p><p>Close medical surveillance is required when prescribing Voltaren to patients with impairment of hepatic function as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with Diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure.</p><p>If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia, rash), Voltaren should be discontinued.&nbsp;</p><p>Hepatitis may occur with diclofenac without prodromal symptoms.&nbsp;</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p><strong>Renal effects:</strong><em> </em></p><p>As fluid retention and oedema have been reported in association with NSAIDs therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications). Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases. Discontinuation therapy is usually followed by recovery to the pre-treatment state.</p><p><strong>Skin effects</strong>:</p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including Voltaren (see section 4.8 Undesirable effects). Patients appear to be at the highest risk of these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Voltaren should be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity.</p><p><strong>SLE and mixed connective tissue disease: </strong></p><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8 Undesirable effects).</p><p><strong>Cardiovascular and cerebrovascular effects: </strong></p><p>Patients with congestive heart failure (NYHA-I) or patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful consideration.</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&rsquo;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and congestive heart failure (NYHA-I) as fluid retention and oedema have been reported in association with NSAID therapy including diclofenac.</p><p>Clinical trial and epidemiological data consistently point towards increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment.</p><p>Patients should remain alert for the signs and symptoms of serious arteriothrombotic events (e.g. chest pain, shortness of breath, weakness, slurring of speech), which can occur without warnings. Patients should be instructed to see a physician immediately in case of such an event.</p><p><strong>Haematological effects: </strong></p><p>During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of the blood count is recommended.</p><p>Voltaren may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5 Interaction with other medicaments and other forms of interactions).&nbsp; Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should be carefully monitored.</p><p><strong>Pre-existing asthma: </strong></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&rsquo;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>&nbsp;</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of<em> </em>bronchial asthma.</p><p><strong>&nbsp;</strong></p><p><strong>Injection site reactions: </strong></p><p>Injection site reactions have been reported after the administration of diclofenac intramuscularly, including injection site necrosis and embolia cutis medicamentosa, also known as Nicolau syndrome (particularly after inadvertent subcutaneous administration). Appropriate needle selection and injection technique should be followed during intramuscular administration of diclofenac (see section 4.2).</p><p><strong>&nbsp;</strong></p><p><strong>Female fertility: </strong></p><p>The use of Voltaren may impair female fertility and is not recommended in women attempting to conceive.&nbsp; In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Voltaren should be considered (see section 4.6 Fertility, pregnancy and lactation).</p><p><strong>&nbsp;</strong></p><p><strong>Excipient(s) with known effect</strong></p><p>This medicine contains 600mg propylene glycol per 3ml ampoule which is equivalent to 200mg/ml.</p><p>&nbsp;</p><p>This medicine contains 120mg benzyl alcohol per 3ml ampoule which is equivalent to 40mg/ml.&nbsp; Benzyl alcohol may cause allergic reactions.&nbsp; Ask your doctor or pharmacist for advice if you are pregnant or breast-feeding or if you have liver or kidney disease.&nbsp; This is because large amounts of benzyl alcohol can build up in your body and may cause side effects (called &lsquo;metabolic acidosis&rsquo;).</p><p>&nbsp;</p><p>The sodium metabisulphite present in solution for injection may rarely cause severe hypersensitivity reactions and bronchospasm.</p><p>&nbsp;</p><p>This medicine contains less than 1mmol sodium (23mg) per 3ml ampoule, that is to say essentially &lsquo;sodium-free&rsquo;.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with diclofenac gastro-resistant tablets and/or other pharmaceutical forms of diclofenac.</p><p><strong>&nbsp;</strong></p><p><strong>Lithium:<em> </em></strong>If used concomitantly, Voltaren may increase plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p><strong>&nbsp;</strong></p><p><strong>Digoxin:</strong>&nbsp; If used concomitantly, Voltaren may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p><strong>&nbsp;</strong></p><p><strong>Diuretics and antihypertensive agents:</strong>&nbsp; Like other NSAIDs, concomitant use of Voltaren with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis.</p><p>&nbsp;</p><p>Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity.</p><p><strong>&nbsp;</strong></p><p><strong>Drugs known to cause hyperkalemia</strong>: Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored (see section 4.4 Special warnings and precautions for use).</p><p><strong>&nbsp;</strong></p><p><strong>Anticoagulants and anti-platelet agents:</strong>&nbsp; Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4 Special warnings and precautions for use).&nbsp; Although clinical investigations do not appear to indicate that diclofenac has an influence on the effect of anticoagulants, there are reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulant concomitantly (see section 4.4 Special warnings and precautions for use).&nbsp; Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required.&nbsp; As with other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet aggregation.</p><p><strong>&nbsp;</strong></p><p><strong>Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids:</strong>&nbsp; Co-administration of diclofenac with other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration.&nbsp; Avoid concomitant use of two or more NSAIDs (see section 4.4 Special warnings and precautions for use).</p><p><strong>&nbsp;</strong></p><p><strong>Selective serotonin reuptake inhibitors (SSRIs):</strong> Concomitant administration of SSRI&rsquo;s may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and precautions for use).</p><p><strong>&nbsp;</strong></p><p><strong>Antidiabetics:</strong>&nbsp; Clinical studies have shown that Voltaren can be given together with oral antidiabetic agents without influencing their clinical effect.&nbsp; However there have been isolated reports of hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p><strong>&nbsp;</strong></p><p><strong>Methotrexate:</strong>&nbsp; Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels.&nbsp; Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increase. Cases of serious toxicity have been reported when methotrexate and NSAIDs including diclofenac are given within 24 hours of each other.&nbsp; This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID.</p><p><strong>&nbsp;</strong></p><p><strong>Ciclosporin:</strong>&nbsp; Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.&nbsp;</p><p><strong>Tacrolimus:&nbsp; </strong>Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.&nbsp; This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor.</p><p><strong>&nbsp;</strong></p><p><strong>Quinolone antibacterials:</strong>&nbsp; Convulsions may occur due to an interaction between quinolones and NSAIDs.&nbsp; This may occur in patients with or without a previous history of epilepsy or convulsions.&nbsp; Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID.</p><p><strong>&nbsp;</strong></p><p><strong>Phenytoin:</strong> When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p><strong>&nbsp;</strong></p><p><strong>Colestipol and cholestyramine: </strong>These agents can induce a delay or decrease in absorption of diclofenac. Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol/ cholestyramine.</p><p><strong>&nbsp;</strong></p><p><strong>Cardiac glycosides:</strong><em>&nbsp; </em>Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><strong>&nbsp;</strong></p><p><strong>Mifepristone:</strong><em>&nbsp; </em>NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p>&nbsp;</p><p><strong>Zidovudine:</strong> Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</p><p><strong>&nbsp;</strong></p><p><strong>Potent CYP2C9 inhibitors:</strong> Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and or cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1% up to approximately 1.5%.</p><p>&nbsp;</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has shown to result in increased pre-and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during organogenetic period. From the 20th week of pregnancy onward, Voltaren use may cause oligohydramnios resulting from foetal renal dysfunction. This may occur shortly after treatment initiation and is usually reversible upon discontinuation. In addition, there have been reports of ductus arterious constriction following treatment in the second trimester, most of which resolved after treatment cessation.&nbsp; Therefore, during the first and second trimester of pregnancy, Voltaren should not be given unless clearly necessary.&nbsp;</p><p>If Voltaren is used by a woman attempting to conceive, or during the first or second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>&nbsp;</p><p>Antenatal monitoring for oligohydramnios and ductus arteriosus constriction should be considered after exposure to diclofenac for several days from gestational week 20 onward. Voltaren should be discontinued if oligohydramnios or ductus arteriosus constriction is found.</p><p>&nbsp;</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:</p><p>- cardiopulmonary toxicity (with premature constriction/closure of the ductus arteriosus and pulmonary</p><p>hypertension)</p><p>- renal dysfunction, (see above);</p><p>&nbsp;</p><p>The mother and the neonate, at the end of the pregnancy, to:</p><p>- possible prolongation of bleeding time, an anti-aggregating effect which may occur even at</p><p>very low doses</p><p>- inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>&nbsp;</p><p>Consequently, Voltaren is contra-indicated during the third trimester of pregnancy.</p><p><strong>&nbsp;</strong></p><p><strong>Lactation</strong></p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore, diclofenac should</p><p>not be administered during breast feeding in order to avoid undesirable effects in the infant (see section</p><p>5.2 Pharmacokinetic properties).</p><p><strong>&nbsp;</strong></p><p><strong>Female fertility</strong></p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in</p><p>women attempting to conceive. In women who may have difficulties conceiving or who are undergoing</p><p>investigation of infertility, withdrawal of diclofenac should be considered. See also section 4.4 Special</p><p>warnings and precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, vertigo, somnolence, central nervous system disturbances, drowsiness or fatigue while taking NSAIDs should refrain from driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention: Very common: (&ge;1/10); common (&ge; 1/100 to &lt;1/10); uncommon (&ge; 1/1,000&nbsp; to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1000); very rare (&lt;1/10,000); not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p>The following undesirable effects include those reported with either short-term or long-term use.</p><p><strong>&nbsp;</strong></p><p><strong>Table 1</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:606px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Infection and Infestations</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p><p>Not known</p></td><td style="vertical-align:top"><p>Injection site abscess.</p><p>Injection site necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leucopoenia, anaemia (including haemolytic and aplastic anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>Very rare</p></td><td style="vertical-align:top"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p><p>Angioneurotic oedema (including face oedema).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>Headache, dizziness.</p><p>Somnolence, tiredness.</p><p>Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p><p>Confusion, hallucinations, disturbances of sensation, malaise.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p><p>Not known</p></td><td style="vertical-align:top"><p>Visual disturbance, vision blurred, diplopia.</p><p>Optic neuritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Very rare</p></td><td style="vertical-align:top"><p>Vertigo.</p><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon*</p></td><td style="vertical-align:top"><p>Myocardial infarction, cardiac failure, palpitations, chest pain.</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Kounis syndrome.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension, hypotension, vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Asthma (including dyspnoea).</p><p>Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia.</p><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly).</p><p>Colitis (including haemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p><p>Ischaemic colitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Transaminases increased.</p><p>Hepatitis, jaundice, liver disorder.</p><p>Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Rash.</p><p>Urticaria.</p><p>Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Impotence.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Rare</p><p>Not known</p></td><td style="vertical-align:top"><p>Injection site reaction, injection site pain, injection site induration.</p><p>Oedema.</p><p>Embolia cutis medicamentosa (Nicolau syndrome).</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>* The frequency reflects data from long-term treatment with a high dose (150 mg/day).</p><p>&nbsp;</p><p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial</p><p>thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac,</p><p>particularly at high doses (150mg daily) and in long term treatment (see sections 4.3 and 4.4 for</p><p>Contraindications and Special warnings and special precautions for use)<em>.</em></p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It</p><p>allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare</p><p>professionals are asked to report any suspected adverse reactions</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC):</p><p>o Fax: +966-11-205-7662</p><p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Safety Department Novartis Consulting AG - Saudi Arabia:</p><p>o Toll Free Number: 8001240078</p><p>o Phone: +966112658100</p><p>o Fax: +966112658107</p><p>o Email: adverse.events@novartis.com</p><p>&bull;&nbsp;&nbsp;&nbsp; Other GCC States:</p><p>-&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong></p><p>There is no typical clinical picture resulting from diclofenac over dosage. Over dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, diarrhoea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting or convulsions.&nbsp; In the case of significant poisoning acute renal failure and liver damage are possible.</p><p><strong>&nbsp;</strong></p><p><strong>Therapeutic measures</strong></p><p>Patients should be treated symptomatically as required.&nbsp; Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered.&nbsp; Alternatively, in adults gastric lavage should be considered within one hour of ingestion of potentially toxic amounts.&nbsp; Frequent or prolonged convulsions should be treated with intravenous diazepam. Other measures may be indicated by the patients clinical condition.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group</strong></p><p>Nonsteroidal anti-inflammatory drugs (NSAIDs).</p><p>&nbsp;</p><p><strong>Mechanism of action</strong></p><p>Voltaren is a nonsteroidal agent with marked analgesic/anti- inflammatory properties.&nbsp; It is an inhibitor of prostaglandin synthetase, (cyclo-oxygenase).&nbsp; Diclofenac sodium <em>in vitro</em> does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in human beings.&nbsp; When used concomitantly with opioids for the management of post-operative pain, Voltaren often reduces the need for opioids.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>After administration of 75mg diclofenac by intramuscular injection, absorption sets in immediately, and mean peak plasma concentrations of about 2.558 &plusmn; 0.968&micro;g/ml (2.5&micro;g/mL <!--[if supportFields]><span
lang=EN-GB style='mso-bidi-font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi'><span style='mso-element:field-begin'></span>SYMBOL
186 \f &quot;Symbol&quot;</span><![endif]--><!--[if supportFields]><span
lang=EN-GB style='mso-bidi-font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:major-bidi'><span style='mso-element:field-end'></span></span><![endif]--> 8&micro;mol/L) are reached after about 20 minutes.&nbsp; The amount absorbed is in linear proportion to the size of the dose.</p><p>&nbsp;</p><p>Intravenous infusion:&nbsp; When 75mg diclofenac is administered as an intravenous infusion over 2 hours, mean peak plasma concentrations are about 1.875 &plusmn; 0.436&micro;g/ml (1.9&micro;g/mL <!--[if supportFields]><span
lang=EN-GB style='mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-begin'></span>SYMBOL 186 \f
&quot;Symbol&quot;</span><![endif]--><!--[if supportFields]><span lang=EN-GB
style='mso-bidi-font-size:11.0pt;font-family:"Times New Roman",serif;
mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:
major-bidi'><span style='mso-element:field-end'></span></span><![endif]--> 5.9&micro;mol/L).&nbsp; Shorter infusions result in higher peak plasma concentrations, while longer infusions give plateau concentrations proportional to the infusion rate after 3 to 4 hours.&nbsp; This is in contrast to the rapid decline in plasma concentrations seen after peak levels have been achieved with oral, rectal or i.m. administration.</p><p><strong>&nbsp;</strong></p><p><strong>Bioavailability</strong>:</p><p>The area under the concentration curve (AUC) after intramuscular or intravenous administration is about twice as large as it is following oral or rectal administration as this route avoids &quot;first-pass&quot; metabolism.</p><p><strong>Distribution</strong></p><p>The active substance is 99.7% protein bound, mainly to albumin (99.4%).</p><p>&nbsp;</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4 hours after the peak plasma values have been attained. The apparent half-life for elimination from the synovial fluid is 3-6 hours. Two hours after reaching the peak plasma values, concentrations of the active substance are already higher in the synovial fluid than they are in the plasma and remain higher for up to 12 hours.</p><p>&nbsp;</p><p>Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose (see section 4.6 Pregnancy and lactation).</p><p><strong>&nbsp;</strong></p><p><strong>Metabolism</strong></p><p>Biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites, most of which are converted to glucuronide conjugates.&nbsp; Two phenolic metabolites are biologically active, but to a much lesser extent than diclofenac.</p><p><strong>&nbsp;</strong></p><p><strong>Elimination</strong></p><p>Total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 mL/min (mean value &plusmn; SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites, including the two active ones, also have short plasma half-lives of 1-3 hours.</p><p>&nbsp;</p><p>About 60% of the administered dose is excreted in the urine in the form of the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the faeces.</p><p><strong>&nbsp;</strong></p><p><strong>Characteristics in patients</strong></p><p><em>Elderly:&nbsp; </em>No relevant age-dependent differences in the drug&#39;s absorption, metabolism or excretion have been observed, other than the finding that in five elderly patients, a 15 minute iv infusion resulted in 50% higher plasma concentrations than expected with young healthy subjects.</p><p>&nbsp;</p><p><em>Patients with renal impairment:&nbsp; </em>In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a creatinine clearance of &lt;10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects. However, the metabolites are ultimately cleared through the bile.</p><p>&nbsp;</p><p><em>Patients with hepatic disease:&nbsp; </em>In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Voltaren ampoules also contain mannitol (E 421), sodium metabisulphite (E 223), benzyl alcohol, propylene glycol (E 1520), sodium hydroxide and water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The ampoules used im or iv as an infusion should not be mixed with other injection solutions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Two years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>Store in the original package in order to protect from light.</p><p>The infusion solution should not be used if crystals or precipitates are observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The glass ampoules (Ph.Eur. Type I) contain colourless to faintly yellow liquid and come in packs of 5.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Intravenous infusions should be freshly made up and used immediately. Once prepared, the infusion should not be stored.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG. 
www.Novartis.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4 February 2023 by MHRA 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>